2011 Q4/Global Life Sciences


Summary

Full results


Rank Chg Organisation name Overall
1 +0 Anergis
8.8
2 +0 Lumavita AG
8.1
3 +21 Max Zeller Söhne AG
7.8
4 +0 Piramal Healthcare
7.8
5 -2 Siegfried AG
7.8
6 +2 Newron
7.7
7 +3 4-Antibody AG
7.6
8 -3 Medinova AG
7.6
9 +93 Schwabe Pharma AG
7.5
10 +3 Kuros Biosurgery AG
7.4
11 +86 Redbiotec AG
7.4
12 -3 Neurimmune Therapeutics AG
7.3
13 -6 Pharmakon Ltd.
7.2
14 +0 Celgene
7.0
15 +0 Renovo
6.9
16 +0 Eisai (company)
6.8
17 +0 Astellas Pharma
6.8
18 -12 Actelion Ltd.
6.7
19 +1 Virbac Schweiz AG
6.7
20 +24 Debiopharm S.A.
6.6
21 +44 Antares Pharma AG
6.6
22 -7 Neurotune
6.6
23 +0 Alkermes
6.6
24 +0 STADA Arzneimittel
6.5
25 +0 Nectar Lifesciences
6.5
26 +0 Aptalis
6.5
27 +0 Orion Pharma
6.5
28 +6 Molecular Partners
6.4
29 +0 MEDA Pharma GmbH
6.4
30 +0 Otsuka Pharmaceutical Co.
6.4
31 -19 BioPartners GmbH
6.3
32 -10 Tricom GmbH, Pharma Division
6.3
33 -19 Helvepharm AG
6.3
34 +0 Menarini
6.3
35 -5 Auris Medical AG
6.2
36 +9 Teva Pharma AG
6.2
37 -12 OMIDA AG
6.2
38 -15 Tillotts Pharma AG
6.2
39 -13 GKL Biotec AG
6.2
40 +12 Sanofi-Aventis
6.1
41 +0 Intercytex
6.0
42 -31 Nycomed International Management GmbH
5.9
43 +40 Lundbeck (Schweiz) AG
5.9
44 +0 Galapagos NV
5.9
45 -14 Octapharma AG
5.9
46 +0 Barr
5.9
47 -14 Lipideon Biotechnology AG
5.9
48 +0 Altana Pharma
5.9
49 -31 Dr. Wild & Co. AG
5.9
50 +0 Allergan
5.9


Changes in rank are compared to 2011 Q3/Global Life Sciences. Since then, 110 sites entered the survey and 18 sites could not be included in the rankings (6 more since last time). Build your own. Report statistics.